Canna~Fangled Abstracts Medicinal cannabis for Australian patients with chronic refractory pain including arthritis Br J Pain. 2023 Apr;17(2):206-217. doi: 10.1177/20494637221147115. Epub 2022 Dec 20. Elise A Schubert 1, Masego T Johnstone 2, Melissa…Freedom WaresApril 19, 2023
Canna~Fangled Abstracts NSW Cannabis Medicines Advisory Service preliminary survey results – Enquirer perceptions and patient outcomes Intern Med J. 2021 Nov 27. doi: 10.1111/imj.15635. Online ahead of print. M Graham 1 2 3 4 5, S Bird 6, Z…Freedom WaresNovember 27, 2021
Canna~Fangled Abstracts Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience BMC Neurol. 2021 Jun 22;21(1):227. doi: 10.1186/s12883-021-02246-0. Marie D'hooghe 1 2, Barbara Willekens 3 4, Valerie Delvaux 5, Miguel D'haeseleer 6, Daniel Guillaume 7, Guy Laureys 8, Guy Nagels 6, Patrick…Freedom WaresJune 22, 2021
Canna~Fangled Abstracts The model of care at a leading medical cannabis clinic in Canada Complement Ther Med. 2021 May 27;102740. doi: 10.1016/j.ctim.2021.102740. Online ahead of print. Erin Prosk 1, Maria Fernanda Arboleda 2, Lucile…Freedom WaresMay 27, 2021
Canna~Fangled Abstracts Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study. 2015 Nov 17;74(3-4):178-185. Trojano M1, Vila C. Author information Abstract BACKGROUND: The prospective, non-interventional Mobility Improvement…Freedom WaresNovember 17, 2015